Baby formula maker China Feihe files for HK IPO again, said to seek $1b

Feihe went private from the New York Stock Exchange in 2013 amid a wave of delistings by U.S.-traded Chinese firms.

A growing awareness of health and wellness among Chinese consumers, combined with a lack of confidence in China’s safety standards, has spurred the country’s companies to look overseas to acquire supplement makers.